Aadi bioscience announces data presentation on incidence of tsc1 and tsc2 alterations in advanced cancers at the annual meeting of the american association for cancer research (aacr)

- first rigorous analysis estimates tsc1 and tsc2 definite impact alteration incidence in u.s. as approximately 12,000 advanced cancer patients in 2030
AADI Ratings Summary
AADI Quant Ranking